AbelZeta
Aaron Pan currently works as a Regulatory Program Management Scientist at CBMG Holdings, managing the submission of documents to the FDA for project advancement. Prior to this, Aaron was a Research Assistant at Tufts University, focusing on enhancing protein cargo delivery efficiency. Aaron also worked as a Research Assistant at Cellular Biomedicine Group, researching production methods for Car-T cells. Aaron holds a Bachelor's degree in Biomedical/Medical Engineering from Boston University and a Master of Science in Biomedical/Medical Engineering from Tufts University.
This person is not in any offices
AbelZeta
1 followers
AbelZeta is a global clinical-stage biopharmaceutical company with centers of excellence in Rockville, Maryland and Shanghai, China. AbelZeta is focusing on developing innovative and proprietary cell-based therapeutic products and is committed to ushering in bespoke treatments that harness the body's own immune system to fight against hematological malignancies and solid tumors, as well as inflammatory and immunological diseases. AbelZeta advances research and development in its own GMP facilities at its centers of excellence for early-stage clinical studies, with a pipeline comprised of CAR-T and TIL therapies.